[EN] QUINOLINE DERIVATIVES AS NPY ANTAGONISTS<br/>[FR] DERIVES DE QUINOLINE (N) EN TANT QU'ANTAGONISTES DU NEUROPEPTIDE Y (NPY)
申请人:HOFFMANN LA ROCHE
公开号:WO2003066055A1
公开(公告)日:2003-08-14
Compounds of formula (I) as well as pharmaceutically acceptable salts and esters thereof, wherein R1, R2, R3, R4 and A have the significance given in claim 1, can be used in the form of pharmaceutical preparations for the treatment or prevention of arthritis, cardiovascular diseases, diabetes, renal failure, eating disorders and obesity.
Quinoline derivatives
申请人:——
公开号:US20030153553A1
公开(公告)日:2003-08-14
Compounds of general formula I
1
as well as pharmaceutically acceptable salts and esters thereof, are potent inhibitors of neuropeptide Y and can be used in the form of pharmaceutical preparations for the treatment or prevention of various disease states and related morbidities including obesity.